Share on StockTwits

Edwards Lifesciences Corp (NYSE:EW) shares reached a new 52-week high during mid-day trading on Tuesday , StockRatingsNetwork.com reports. The stock traded as high as $99.35 and last traded at $98.67, with a volume of 452,358 shares traded. The stock had previously closed at $98.53.

EW has been the subject of a number of recent research reports. Analysts at JMP Securities raised their price target on shares of Edwards Lifesciences Corp from $97.00 to $120.00 in a research note on Thursday, August 21st. They now have an “outperform” rating on the stock. Separately, analysts at Stifel Nicolaus raised their price target on shares of Edwards Lifesciences Corp from $90.00 to $100.00 in a research note on Thursday, July 31st. Finally, analysts at JPMorgan Chase & Co. raised their price target on shares of Edwards Lifesciences Corp from $78.00 to $90.00 in a research note on Thursday, July 31st. Five analysts have rated the stock with a hold rating and eight have given a buy rating to the company. The stock currently has an average rating of “Buy” and an average price target of $91.50.

The stock’s 50-day moving average is $91.07 and its 200-day moving average is $81.15. The company has a market cap of $10.477 billion and a price-to-earnings ratio of 14.22.

Edwards Lifesciences Corp (NYSE:EW) last posted its quarterly earnings results on Tuesday, July 29th. The company reported $0.88 EPS for the quarter, beating the Thomson Reuters consensus estimate of $0.77 by $0.11. The company had revenue of $547.00 million for the quarter, compared to the consensus estimate of $545.10 million. During the same quarter in the prior year, the company posted $0.82 earnings per share. The company’s quarterly revenue was up 11.2% on a year-over-year basis. On average, analysts predict that Edwards Lifesciences Corp will post $3.29 earnings per share for the current fiscal year.

In other Edwards Lifesciences Corp news, VP Larry L. Wood unloaded 63,752 shares of the company’s stock in a transaction that occurred on Monday, August 18th. The shares were sold at an average price of $97.85, for a total transaction of $6,238,133.20. The transaction was disclosed in a document filed with the SEC, which is available at this link.

Edwards Lifesciences Corporation (NYSE:EW) is focused on technologies that treat structural heart disease and critically ill patients.

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.